DocDollars

Livanova USA, Inc.

TX · United States · Reporting entity ID 100000176739

Total reported 2019–2025
$166.2M
#67 of 2,960 reporting companies — 0.2% of all reported industry payments
$114.7M in general payments across 53,781 records, plus $51.5M in research funding across 17,211 records.

How it breaks down

General payments $114,714,458
Research funding $51,516,775

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Livanova USA, Inc. reported $166.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #67 of 2,960 reporting companies. 31% of that was research funding and 69% general payments such as consulting, speaking, food and travel. 53,781 general payment records and 17,211 research records were filed.

Common questions about Livanova USA, Inc.

How much has Livanova USA, Inc. paid US doctors?

Livanova USA, Inc. reported $166,231,234 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $114,714,458 in general payments, $51,516,775 in research funding.

How does Livanova USA, Inc. rank among drug and device companies?

It ranks #67 of 2,960 reporting entities by total reported value, about 0.2% of all industry payments in the dataset.

Does a payment from Livanova USA, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.